GOVX
Price:
$2.21
Market Cap:
$20.85M
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccines against (COVID-19), human immunodeficiency virus (HIV); Zika virus; malaria; and hemorrhagic fever viruses, such as Ebola, Sudan, Marburg, and Lassa, as well as therapeutic vaccines for HIV, chronic Hepatitis B infections, and solid tumor cancers. The company has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; Centers for Disease Control and Preve...[Read more]
Industry
Biotechnology
IPO Date
2020-09-25
Stock Exchange
NASDAQ
Ticker
GOVX
According to GeoVax Labs, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 4.17. This represents a change of 111.70% compared to the average of 1.97 of the last 4 quarters.
The mean historical Current Ratio of GeoVax Labs, Inc. over the last ten years is 4.20. The current 4.17 Current Ratio has changed 9.82% with respect to the historical average. Over the past ten years (40 quarters), GOVX's Current Ratio was at its highest in in the June 2021 quarter at 54.75. The Current Ratio was at its lowest in in the June 2019 quarter at 0.20.
Average
4.20
Median
2.19
Minimum
0.22
Maximum
12.63
Discovering the peaks and valleys of GeoVax Labs, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 5.59%
Maximum Annual Current Ratio = 12.63
Minimum Annual Increase = -84.89%
Minimum Annual Current Ratio = 0.22
Year | Current Ratio | Change |
---|---|---|
2023 | 2.24 | -63.24% |
2022 | 6.10 | 184.88% |
2021 | 2.14 | -83.06% |
2020 | 12.63 | 5.59% |
2019 | 0.22 | -41.86% |
2018 | 0.38 | -30.91% |
2017 | 0.55 | -62.48% |
2016 | 1.47 | -84.89% |
2015 | 9.74 | 48.65% |
2014 | 6.55 | -24.15% |
The current Current Ratio of GeoVax Labs, Inc. (GOVX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
3.49
5-year avg
4.67
10-year avg
4.20
GeoVax Labs, Inc.’s Current Ratio is greater than eFFECTOR Therapeutics, Inc. (1.03), less than Virios Therapeutics, Inc. (7.27), less than Zura Bio Limited (10.36), greater than Navidea Biopharmaceuticals, Inc. (0.56), less than ZyVersa Therapeutics, Inc. (33.83), less than Phio Pharmaceuticals Corp. (6.38), greater than Sonnet BioTherapeutics Holdings, Inc. (0.66), greater than 180 Life Sciences Corp. (0.19), less than Cardio Diagnostics Holdings, Inc. (8.51), greater than Kiromic BioPharma, Inc. (0.22), greater than Apexigen, Inc. (1.29), greater than Altamira Therapeutics Ltd. (1.38), greater than Avenue Therapeutics, Inc. (2.70), greater than Quoin Pharmaceuticals, Ltd. (3.02), greater than Blue Water Vaccines, Inc. (0.06), greater than PaxMedica, Inc. Common Stock (0.38), greater than Revelation Biosciences, Inc. (1.64), greater than Hillstream BioPharma, Inc. (2.25), greater than Jaguar Health, Inc. (1.84), greater than Onconova Therapeutics, Inc. (1.07), greater than iBio, Inc. (3.37), greater than Ocugen, Inc. (2.58),
Company | Current Ratio | Market cap |
---|---|---|
1.03 | $941.00 | |
7.27 | $206.50K | |
10.36 | $155.40M | |
0.56 | $10.01K | |
33.83 | $2.74M | |
6.38 | $2.35M | |
0.66 | $4.33M | |
0.19 | $3.70M | |
8.51 | $41.65M | |
0.22 | $1.42M | |
1.29 | $9.57M | |
1.38 | $1.13M | |
2.70 | $3.70M | |
3.02 | $2.64M | |
0.06 | $3.41M | |
0.38 | $719.12K | |
1.64 | $2.53M | |
2.25 | $4.17M | |
1.84 | $11.52M | |
1.07 | $20.90M | |
3.37 | $21.59M | |
2.58 | $215.61M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like GeoVax Labs, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like GeoVax Labs, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is GeoVax Labs, Inc.'s Current Ratio?
How is the Current Ratio calculated for GeoVax Labs, Inc. (GOVX)?
What is the highest Current Ratio for GeoVax Labs, Inc. (GOVX)?
What is the 3-year average Current Ratio for GeoVax Labs, Inc. (GOVX)?
What is the 5-year average Current Ratio for GeoVax Labs, Inc. (GOVX)?
How does the current Current Ratio for GeoVax Labs, Inc. (GOVX) compare to its historical average?